Isoflurane, but not halothane, induces protection of human myocardium via adenosine A1 receptors and adenosine triphosphate-sensitive potassium channels

Anesthesiology

Volumn 92, Issue 6, 2000, Pages 1692-1701

  Roscoe, Amy K ^b   Christensen, Jared D ^b   Lynch III, Carl ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b NONE

Author keywords

Isolated muscles; Myocardial protection; Volatile anesthetics

Indexed keywords

ADENOSINE A1 RECEPTOR; HALOTHANE; ISOFLURANE; POTASSIUM CHANNEL;

ARTICLE; CONTROLLED STUDY; DRUG EFFECT; DRUG SCREENING; HEART MUSCLE CONTRACTILE FORCE; HEART MUSCLE ISCHEMIA; HEART PROTECTION; HUMAN; HUMAN CELL; HUMAN TISSUE; POTASSIUM CURRENT; PRIORITY JOURNAL;

EID: 0034099583     PISSN: 00033022     EISSN: None     Source Type: Journal    
DOI: 10.1097/00000542-200006000-00029     Document Type: Article

References (43)

1. Slogoff S, Keats AS: Does perioperative myocardial ischemia lead to post-operative myocardial infarction? ANESTHESIOLOGY 1985; 62:107-14
2. Mangano DT, Browner WS, Hollenberg M, London MJ, Tubau JF, Tateo IM, Group SPI: Association of perioperative myocardial ischemia with cardiac morbidity and mortality in men undergoing noncardiac surgery. N Engl J Med 1990; 323:1781-8
3. Reiz S, Balfors E, Sorensen MB, Ariola S Jr, Friedman A, Truedsson H: Isoflurane: A powerful coronary vasodilator in patients with coronary artery disease. ANESTHESIOLOGY 1983; 59:91-7
4. Becker LC: Is isoflurane dangerous for the patient with coronary disease? ANRSTHESIOLOGY 1986; 66:259-61
5. Buffington CW, Romson JL, Levine A, Duttlinger NC, Huang AH: Isoflurane induces coronary steal in a canine model of chronic coronary occlusion. ANESTHESIOLOGY 1987; 66:280-92
6. Murry CE, Jennings RB, Reimer KA: Preconditioning with ischemia: A delay of lethal cell injury in ischemic myocardium. Circulation 1986; 74:1124-36
7. Ping P, Zhang J, Qiu Y, Tang X-L, Manchikalapudi S, Cao X, Bolli R: Ischemic preconditioning induces selective translocation of protein kinase C isoforms ∈ and η the heart of conscious rabbits without subcellular redistribution of total protein kinase C activity. Circ Res 1997; 81:404-14
8. Van Winkle DM, Thornton JD, Downey DM, Downey JM: The natural history of preconditioning: Cardioprotection depends on duration of transient ischemia and time to subsequent ischemia. Coron Artery Dis 1991; 2:613-9
9. Parratt JR: Protection of the heart by preconditioning: Mechanisms and possibilities for pharmacologic exploitation. Trends Pharmacol Sci 1994; 15:19-25
10. Liu Y, Sato T, O'Rourke B, Marban E: Mitochondrial ATP-dependent potassium channels? Novel effectors of cardioprotection? Circulation 1998; 97:2463-9
11. ATP channel by glyburide and 5-hydroxydecanoate. J Biol Chem 1998; 273:13578-82
12. Mizumura T, Nithipatikom K, Gross GJ: Bimakalim, an ATP-sensitive potassium channel opener, mimics the effects of ischemic preconditioning to reduce infarct size, adenosine release and neutrophil function in dogs. Circulation 1995; 92:1236-45
13. Auchampach JA, Grover GJ, Gross GJ: Blockade of ischemic preconditioning in dogs by the novel ATP-dependent potassium channel antagonist sodium 5-hydroxydecanoate. Cardiovasc Res 1992; 26: 1054-62
14. + channel. Circ Res 1995; 77:1030-5
15. Haessler R, Kuzume K, Chein GL, Wollf RA, Davis RF, Van Winkle DM: Anaesthetics alter the magnitude of infarct limitation by ischaemic preconditioning. Cardiovasc Res 1994; 28:1574-80
16. ATP) channels. ANESTHESIOLOGY 1996; 85:794-807
17. Belhomme D, Peynet J, Louzy M, Launey J-M, Kitakaze M, Menasche P: Evidence for preconditioning by isoflurane in coronary artery bypass graft surgery. Circulation 1999; 100(suppl II):II340-4
18. + channels in rabbit ventricular myocardium. Biochem Biophys Res Commun 1996; 229:852-6
19. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC: Role of adenosine in isoflurane-induced cardioprotection. ANESTHESIOLOGY 1997;86:1128-39
20. 1-receptor stimulation. Br J Pharmacol 1998; 124:639-46
21. 3 receptors in protection of isolated human atrial muscle against simulated ischemia. Cardiovasc Res 1997; 36:52-9
22. Nánási P, Varro A, Lathrap D: Isolation of human ventricular and atrial cardiomyocytes: Technical note. Cardioscience 1993; 4:111-6
23. Cleveland JC Jr, Meldrum DR, Rowland RT, Cain BS, Meng X, Gamboni-Robertson F, Banerjee A, Harken AH: Ischemic preconditioning of human myocardium: Protein kinase C mediates a permissive role for α1-adrenoceptors. Am J Physiol 1997; 42:H902-8
24. Merin RG: Are the myocardial function and metabolic effects of isoflurane really different from those of halothane and enflurane? ANESTHESIOLOGY 1981; 55:390-408
25. Lynch C III: Differential depression of myocardial contractility by halothane and isoflurane in vitro. ANESTHESIOLOGY 1986; 64:620-31
26. Novalija E, Fujita S, Kampine JP, Stowe DF: Sevoflurane mimics ischemic preconditioning effects on coronary flow and nitric oxide release in isolated hearts. ANESTHESIOLOGY 1999; 91:701-12
27. Lathrop DA, Contney SJ, Bosnjak ZJ, Stowe DJ: Reversal of hypothermia-induced action potential lengthening by the KATP channel agonist bimakalim in isolated guinea pig ventricular muscle. Gen Pharmacol 1998; 31:125-31
28. Saito W, Noguchi K, Okazaki K, Matsuda T, Kato Y, Tanaka H, Shigenobu K: Temperature-sensitive effects of potassium channel openers on isolated guinea pig myocardium and aorta. J Cardiovasc Pharmacol 1998; 31:327-9
29. Cleveland JC Jr, Wollmering MM, Meldrum DR, Rowland RT, Fehring TF, Sheridan BC, Harken AH, Banerjee A. Ischemic preconditioning in human and rat ventricle. Am J Physiol 1996; 271:H1786-94
30. Ovize M, Przylenk K, Hale SL, Kloner R: Preconditioning does not atenuate myocardial stunning. Circulation 1992; 85:2247-54
31. Cleveland JC Jr, Meldrum DR, Rowland RT, Banerjee A, Harken AH: Adenosine preconditioning of human myocardium is dependent upon the ATP-sensitive K+ channel. J Mol Cell Cardiol 1997; 29: 175-82
32. + currents by protein kinase C and adenosine: Implications for ischemic preconditioning. Circ Res 1996; 78:443-54
33. ATP channel opener bimakalim on coronary blood flow, monophasic action potential duration, and infarct size in dogs. Circulation 1994; 89:1769-75
34. + channels by protein kinase C. Circ Res 1998; 83:110-4
35. ATP-channel opener, is cardioprotective in ischemic rabbit myocardium (abstract). Circ Suppl 1998; 98:1343
36. + channels: Possible mechanism of cardioprotection. Circ Res 1997; 81:1072-82
37. Cason BA, Shubayev I, Mickey RF: Blockade of adenosine triphosphate-sensitive potassium channels eliminates isoflurane-induced coronary artery vasodilation. ANESTHESIOLOGY 1994; 81:1245-55
38. Hartman JC, Kampine JP, Schmeling WT, Warltier DC: Stealprone coronary circulation in chronically instrumented dogs: Isoflurane versus adenosine. ANESTHESIOLOGY 1991; 74:744-56
39. Cason BA, Gamperl AK, Slocum RE, Hickey RF: Anesthetic-induced preconditioning: Previous administration of isoflurane decreases myocardial infarct size in rabbits. ANESTHESIOLOGY 1997; 87: 1182-90
40. Kersten JR, Orth KG, Pagel PS, Mei DA, Gross GJ, Warltier DC: Role of adenosine in isoflurane-induced cardioprotection. ANESTHESIOLOGY 1997, 86:1128-39
41. ATP channels: Reduction of myoeardial infarct size with an acute memory phase. ANESTHESIOLOGY 1997; 87:361-70
42. ATP channels by dinitrophenol separate from metabolic inhibition. J Memb Biol 1997; 157:203-14
43. Cope DK, Impastato WK, Cohen MV, Downey JM: Volatile anesthetics protect the ischemic rabbit myocardium from infarction. ANESTHESIOLOGY 1997; 109:699-709